Dr. Venkat Reddy Thangella
Head Business Development Group,
Purification Technologies – India, SEA & ANZ
Dr Venkat Reddy Thangella holds a M.Sc. degree in Chemistry from Osmania University, India, also a M.Sc. in Display Technology at Högskolan Dalarna University, Sweden, and a Ph.D. in Chemistry from the Centre for Pharmaceutical Research and Development at ITT Dublin, Ireland. His first industrial career started in the Process Development Centre at Pfizer Global Manufacturing, Pfizer Pharmaceuticals, Ireland. He then moved to India and joined Sapala Organics Pvt. Ltd., as a Researcher in Medicinal chemistry. Later he joined Issar Pharmaceuticals
Pvt. Ltd., where he was leading the complete Peptide manufacturing, Purification, and Lyophilization divisions. Then later he moved to China and worked as a Chief Application Scientist at Hanbon Science Technology Co. Ltd., China. There he managed their small- to large-scale Preparative Chromatography Application facilities. Dr Venkat has broad experience in the Synthesis, Process development, Purification, and scale-up of Peptide APIs, with extensive knowledge of handling sophisticated instruments in Peptide API manufacturing including Auto Peptide synthesizers, Prep HPLC (DAC/SAC), and Flash Chromatography, and Lyophilizers. He is also the author of various publications in reputed international journals. Currently, Dr Venkat holds a Sr Manager - Business Development position at Phenomenex India. In this current role, Dr Venkat is responsible for leading India Business development group and managing business development in Pharma, Biopharma, Food/Environmental Testing, Clinical and Forensic, and Life Science Industries. He is also responsible for India & JKOSEA regions Bulk media and Preparative Chromatography Business Development and Sales